TEVA PHARMACEUTICAL INDUSTRIES LTD Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders
Financial Statements › Shareholders' Equity › Noncontrolling Interest Items
us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders · last filed 2026-02-03
- TEVA PHARMACEUTICAL INDUSTRIES LTD noncontrolling interest, decrease from distributions to noncontrolling interest holders for the quarter ending 2025-12-31 was $0.00.
- TEVA PHARMACEUTICAL INDUSTRIES LTD noncontrolling interest, decrease from distributions to noncontrolling interest holders for the quarter ending 2025-09-30 was $4.00M.
- TEVA PHARMACEUTICAL INDUSTRIES LTD noncontrolling interest, decrease from distributions to noncontrolling interest holders for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- TEVA PHARMACEUTICAL INDUSTRIES LTD noncontrolling interest, decrease from distributions to noncontrolling interest holders for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- TEVA PHARMACEUTICAL INDUSTRIES LTD noncontrolling interest, decrease from distributions to noncontrolling interest holders for fiscal 2025 was $4.00M, a 77.78% decline from fiscal 2024.
- TEVA PHARMACEUTICAL INDUSTRIES LTD noncontrolling interest, decrease from distributions to noncontrolling interest holders for fiscal 2024 was $18.00M, a 73.53% decline from fiscal 2023.
- TEVA PHARMACEUTICAL INDUSTRIES LTD noncontrolling interest, decrease from distributions to noncontrolling interest holders for fiscal 2023 was $68.00M.
| Period end | Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 3 month | Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 6 month | Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 9 month | Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $4.00M derived: sum of 2 quarters · filed 2026-02-03 | $4.00M 10-K · filed 2026-02-03 | |
| 2025-09-30 | $4.00M 10-Q · filed 2025-11-05 | $4.00M 10-Q · filed 2025-11-05 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $0.00 derived: sum of 2 quarters · filed 2026-02-03 | $0.00 derived: sum of 3 quarters · filed 2026-02-03 | $18.00M 10-K · filed 2026-02-03 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2025-11-05 | $18.00M 10-Q · filed 2025-11-05 | $19.00M derived: sum of 4 quarters · filed 2026-02-03 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $18.00M 10-Q · filed 2025-07-30 | $19.00M derived: sum of 3 quarters · filed 2026-02-03 | $86.00M derived: sum of 4 quarters · filed 2026-02-03 |
| 2024-03-31 | $18.00M 10-Q · filed 2025-05-07 | $19.00M derived: sum of 2 quarters · filed 2026-02-03 | $86.00M derived: sum of 3 quarters · filed 2026-02-03 | |
| 2023-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $68.00M derived: sum of 2 quarters · filed 2026-02-03 | $68.00M 10-K · filed 2026-02-03 | |
| 2023-09-30 | $67.00M 10-Q · filed 2024-11-06 | $67.00M 10-Q · filed 2024-11-06 |